Multiple inflammation and metabolism-related proteins

The term Multiple inflammation and metabolism-related proteins refers to a broad and heterogeneous group of biological molecules that mediate the complex interplay between the immune system and metabolic pathways. This category typically encompasses pro-inflammatory cytokines such as Tumor Necrosis Factor-alpha and Interleukin-6, adipokines such as Leptin and Adiponectin, and various intracellular signaling proteins like JNK and IKK that are involved in metainflammation (Hotamisligil, Nature, 2006). These proteins play a pivotal role in the development of chronic metabolic diseases, including obesity-induced insulin resistance, type 2 diabetes, and atherosclerosis, by linking nutrient excess to inflammatory responses (Gregor & Hotamisligil, Annu Rev Immunol, 2011). Because this designation represents a functional grouping rather than a single molecular entity, it is not considered a specific therapeutic target in drug discovery. Instead, it serves as a descriptive classification for biomarkers or a set of distinct targets that are often studied together to understand systemic physiological dysregulation (Medzhitov, Nature, 2008). Consequently, therapeutic intervention usually focuses on specific individual proteins within this group rather than the collective category itself.

Other names

Metainflammation-related proteinsMetabolic-inflammatory markersInflammatory and metabolic biomarkers

Not applicable as this refers to a broad category of proteins rather than a single drug target; however, individual components are targeted via inhibition of cytokines or modulation of metabolic pathways.